The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States
Open accessAbstract
Purpose: Despite advances in the treatment of HIV, HIV-infected people remain at increased risk for many cancers, and the number of non–AIDS-defining cancers is increasing with the aging of the HIV-infected population. No prior study has comprehensively evaluated the effect of HIV on cancer-specific mortality. Patients and Methods: We identified cases of 14 common cancers occurring from 1996 to 2010 in six US states participating in a linkage of cancer and HIV/AIDS registries. We used Cox regression to examine the association between patient HIV status and death resulting from the presenting cancer (ascertained from death certificates), adjusting for age, sex, race/ethnicity, year of cancer diagnosis, and cancer stage. We included 1,816,461 patients with cancer, 6,459 (0.36%) of whom were HIV infected. Results: Cancer-specific mortality was significantly elevated in HIV-infected compared with HIV-uninfected patients for many cancers: colorectum (adjusted hazard ratio [HR], 1.49; 95% CI, 1.21 to 1.84), pancreas (HR, 1.71; 95% CI, 1.35 to 2.18), larynx (HR, 1.62; 95% CI, 1.06 to 2.47), lung (HR, 1.28; 95% CI, 1.17 to 1.39), melanoma (HR, 1.72; 95% CI, 1.09 to 2.70), breast (HR, 2.61; 95% CI, 2.06 to 3.31), and prostate (HR, 1.57; 95% CI, 1.02 to 2.41). HIV was not associated with increased cancer-specific mortality for anal cancer, Hodgkin lymphoma, or diffuse large B-cell lymphoma. After further adjustment for cancer treatment, HIV remained associated with elevated cancer-specific mortality for common non–AIDS-defining cancers: colorectum (HR, 1.40; 95% CI, 1.09 to 1.80), lung (HR, 1.28; 95% CI, 1.14 to 1.44), melanoma (HR, 1.93; 95% CI, 1.14 to 3.27), and breast (HR, 2.64; 95% CI, 1.86 to 3.73). Conclusion: HIV-infected patients with cancer experienced higher cancer-specific mortality than HIV-uninfected patients, independent of cancer stage or receipt of cancer treatment. The elevation in cancer-specific mortality among HIV-infected patients may be attributable to unmeasured stage or treatment differences as well as a direct relationship between immunosuppression and tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · cited 1×
“Additional evidence for this hypothesis is provided by the observation that lower numbers of tumor-infiltrating lymphocytes, including T cells, have been associated with poor prognosis in clinical studies of patients with common malignancies, including melanoma and colorectal cancer.(20-22) Clinical trials have demons…”
BackgroundSpectrum of cancer risk among US solid organ transplant recipients
Engels, E. A., Pfeiffer, R. M., Fraumeni, J. F., Kasiske, B. L., Israni, A. K., Snyder, J. J., Wolfe, R. A., Goodrich, N. P., Bayakly, A. R., Clarke, C. A., et al. (2011) · JAMA · doi:10.1001/jama.2011.1592 · Cited by 1,524 · cited 1×
“Immunosuppression, whether in the context of HIV infection or organ transplantation, increases risk most markedly for cancers arising from infections.(1,19) Given our findings, we speculate that a more overarching mechanism may exist whereby immunosuppression alters tumor progression, regardless of the factors respons…”
BackgroundSelf-citationKochenderfer, J. N., Dudley, M. E., Feldman, S. A., Wilson, W. H., Spaner, D. E., Maric, I., Stetler-Stevenson, M., Phan, G. Q., Hughes, M. S., Sherry, R. M., et al. (2012) · Blood · doi:10.1182/blood-2011-10-384388 · Cited by 1,440
Competing Risk Regression Models for Epidemiologic Data
Lau, B., Cole, S. R., & Gange, S. J. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp107 · Cited by 1,403
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., & Ohtani, H. (1998) · PubMed · Cited by 1,193
Clemente, C. G., Mihm, M. C., Bufalino, R., Zurrida, S., Collini, P., & Cascinelli, N. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1303::aid-cncr12>3.0.co;2-5 · Cited by 1,171
Patel, P., Hanson, D. L., Sullivan, P. S., Novak, R. M., Moorman, A. C., Tong, T. C., Holmberg, S. D., Brooks, J. T., & for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00005 · Cited by 942
Cancer Burden in the HIV-Infected Population in the United States
Shiels, M. S., Pfeiffer, R. M., Gail, M. H., Hall, H. I., Li, J., Chaturvedi, A. K., Bhatia, K., Uldrick, T. S., Yarchoan, R., Goedert, J. J., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr076 · Cited by 778
Self-citationTrends in cancer risk among people with AIDS in the United States 1980–2002
Engels, E. A., Pfeiffer, R. M., Goedert, J. J., Virgo, P., McNeel, T. S., Scoppa, S. M., & Biggar, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000238411.75324.59 · Cited by 775
Self-citationGuiguet, M., Boué, F., Cadranel, J., Lang, J.-M., Rosenthal, E., & Costagliola, D. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70282-7 · Cited by 571
A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals
Shiels, M. S., Cole, S. R., Kirk, G. D., & Poole, C. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b327ca · Cited by 516
Self-citationEltom, M. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1204 · Cited by 270
Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States
Robbins, H. A., Shiels, M. S., Pfeiffer, R. M., & Engels, E. A. (2014) · AIDS · doi:10.1097/qad.0000000000000163 · Cited by 235
Self-citationBedimo, R. J., McGinnis, K. A., Dunlap, M., Rodriguez-Barradas, M. C., & Justice, A. C. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b033ab · Cited by 202
Barillari, G., Sgadari, C., Valeria Fiorelli, A., Samaniego, F., Colombini, S., Manzari, V., Modesti, A., Nair, B. C., Cafaro, A., Stürzl, M., et al. (1999) · PubMed · Cited by 154
Bruyand, M., Thiébaut, R., Lawson‐Ayayi, S., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605594 · Cited by 118
Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy
Achenbach, C. J., Cole, S. R., Kitahata, M. M., Casper, C., Willig, J. H., Mugavero, M. J., & Saag, M. S. (2010) · AIDS · doi:10.1097/qad.0b013e3283437f77 · Cited by 111
Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals
Suneja, G., Shiels, M. S., Melville, S., Williams, M. A., Rengan, R., & Engels, E. A. (2012) · AIDS · doi:10.1097/qad.0b013e32835ad56e · Cited by 106
Self-citationContribution of HIV infection to mortality among cancer patients in Uganda
Coghill, A. E., Newcomb, P. A., Madeleine, M. M., Richardson, B. A., Mutyaba, I., Okuku, F. M., Phipps, W. T., Wabinga, H., Orem, J., & Casper, C. (2013) · AIDS · doi:10.1097/01.aids.0000433236.55937.cb · Cited by 79
Self-citationPrevalence of HIV Infection among U.S. Hodgkin Lymphoma Cases
Shiels, M. S., Koritzinsky, E. H., Clarke, C. A., Suneja, G., Morton, L. M., & Engels, E. A. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0865 · Cited by 73
Self-citationMortality due to cancer among people with AIDS
Simard, E. P., Pfeiffer, R. M., & Engels, E. A. (2012) · AIDS · doi:10.1097/qad.0b013e328353f38e · Cited by 33
Self-citationNyagol, J., Falco, G. D., Lazzi, S., Luzzi, A., Cerino, G., Shaheen, S., Palummo, N., Bellan, C., Spina, D., & Leoncini, L. (2008) · Journal of Hematopathology · doi:10.1007/s12308-008-0002-z · Cited by 17
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Cancer statistics for Hispanics/Latinos, 2015
Siegel, R. L., Fedewa, S. A., Miller, K. D., Goding‐Sauer, A., Pinheiro, P. S., Martinez‐Tyson, D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21314 · Cited by 468
Liu, G., Sharma, M., Tan, N., & Barnabas, R. V. (2018) · AIDS · doi:10.1097/qad.0000000000001765 · Cited by 421
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 320
Wing, E. J. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.10.004 · Cited by 287
Metadata
- Authors
- Coghill, A. E., Shiels, M. S., Suneja, G., & Engels, E. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-07-20
- Volume
- 33
- Issue
- 21
- Pages
- 2376-2383
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2127129197
- Cited by
- 365
- References
- 30
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.